Women with IBD Show Higher Psychophysiological Burden in Comparison to Men with IBD
<b>Background:</b> Inflammatory bowel disease (IBD) remains an incurable illness. Patients with IBD show gender-specific differences in various aspects of the disease. There is still uncertainty about the causality of the differences. <b>Methods:</b> The aim of this study was to determine the most relevant psychophysiological gender-specific differences in IBD. For this purpose, a questionnaire survey was conducted on disease activity and psychological concomitant diseases in patients with IBD (n = 300). Among the 218 patients with IBD who provided gender information, both genders were equally distributed. <b>Results:</b> Females with IBD are significantly more affected by IBD-related symptoms than men. Disease activity Scores Harvey-Bradshaw Index (HBI), Partial Mayo Score (pMAYO) showed no significant differences between the sexes in the subgroups with CD (HBI, m: 3 (IQR 1-6), w: 4 (IQR 2-8), <i>p</i> = 0.0677) and UC (pMAYO, m: 1 (IQR 0-4), w: 3 (IQR 0-5), <i>p</i> = 0.2118). IBD Questionnaire (IBDQ)shows significant differences in the gender-specific analysis. The mean value of the IBDQ total score of the female participants was 4.4 (SD 1.1) and that of men was 5.0 (SD 1.0) (<i>p</i> = 0.0002). <b>Conclusions:</b> There is a great need to investigate the causality of gender-specific differences in greater depth.
Authors
- Ann Christina Foldenauer (ORCID: https://orcid.org/0000-0003-2049-3204)
- Sandra Plachta‐Danielzik (ORCID: https://orcid.org/0000-0002-1945-4198)
- A Thomann (ORCID: https://orcid.org/0000-0002-7964-4284)
- Stefan Zeuzem (ORCID: https://orcid.org/0000-0002-0845-6833)
- Bernd Bokemeyer (ORCID: https://orcid.org/0000-0003-2016-6991)
- Alica Kubesch (ORCID: https://orcid.org/0000-0002-8627-6088)
- Irina Blumenstein (ORCID: https://orcid.org/0000-0002-7841-0494)
- F. Schulz
- Thomas Krause
- Andrea O. Tal
- Lara Weidmann
Institutions
- Goethe University Frankfurt (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Klinikum Hanau (DE)
- Fraunhofer Institute for Translational Medicine and Pharmacology (DE)
- University Hospital Frankfurt (DE)
- University Medical Centre Mannheim (DE)
- Clinical Research Center Kiel (DE)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2024-12-20
- DOI
- https://doi.org/10.3390/jcm13247806
- Citations
- 4
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.86
Funders
- Pfizer
- Gilead Sciences
- Biogen
- Celltrion
- Novo Nordisk
- Swedish Orphan Biovitrum
- Allergan